Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/VIVUS-INC-46214309/news/VIVUS-Completes-Enrollment-in-Phase-4-Safety-and-Efficacy-Study-of-Qsymia-in-Adolescents-30092799/?utm_source=whatsapp&utm_medium=social&utm_campaign=share